I'm on the record as an optimist for Y-mAbs Therapeutics, Inc. (YMAB), with particular enthusiasm for what I was seeing with their modular SADA platform. To date, that enthusiasm hasn't really borne ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results